News

Soluble biglycan induces EPO production and polycythemia

25.11.2016 | Polycythemia is a disease characterized by an increased number of mature erythrocytes in the...

CIP2As function in the immune system

30.09.2016 | The oncoprotein Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) has been documented to be a...

Pts and its role in obesity

16.09.2016 | Tetrahydrobiopterin (BH4) is an essential cofactor for the aromatic amino acid hydroxylases,...

Phenotype your mouse model

GMC I: 

  1. Systemic, comprehensive phenotyping in 14 different disease areas
  2. Customized primary phenotypic screening in specific areas of interest (e.g. behavior, neurology and neuropathology)

GMC II: 

  1. Hypothesis-driven phenotypic analysis using environmental challenges
  2. Combining environmental challenges

GMCIII:

  1. Systemic analysis of compounds and drugs

TÜV Süd certified Quality Management

Collaborators in primary screening per country

View results of mutant lines

View the results of mutant mouse lines in the GMC phenomap

IMPC - Intl Mouse Phenotyping Consortium

How primary mouse phenotyping leads to novel insights for human health

Mouse phenotyping helps to better understand human diseases. Read more how systemic primary screening of mouse mutants uncovers unexpected new gene functions.

The GMC Consortium:

We are partners in: